Immuneering Corp — Director's Dealing 2022

Nov 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2022-10-31

Reporting Person: Neufeld Leah R (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-31	Stock Option	$13.85	A	88600	Acquired	2032-10-31	Class A Common Stock (88600)	Direct

Footnotes

F1: The option vests and becomes exercisable as to 25% of the underlying shares on October 17, 2023 and then in equal monthly installments over the subsequent three years, subject to Ms. Neufeld's continued employment through each applicable vesting date.